等待开盘 11-04 09:30:00 美东时间
+0.460
+7.35%
Nebius's 500% AI-fueled surge is testing ETF managers as funds weigh exposure to this high-flying, high-risk cloud contender.
11-01 21:02
今日重点评级关注:摩根士丹利:维持Viking Therapeutics"超配"评级,目标价从98美元升至102美元;摩根大通:维持IDEAYA Biosciences"超配"评级,目标价从74美元升至79美元
10-24 09:51
今日重点评级关注:Maxim Group:维持Rani Therapeutics Hldgs"买入"评级,目标价从5美元升至10美元;韦德布什:维持Corbus Pharmaceuticals"跑赢大市"评级,目标价从31美元升至38美元
10-21 18:13
GRAIL (NASDAQ:GRAL) has entered into a securities purchase agreement to raise $325M. Pursuant to the terms of the securities purchase agreement, GRAIL has agreed to issue and sell 4.64M common shares ...
10-20 18:48
HC Wainwright & Co. analyst Scott Buck maintains Veritone (NASDAQ:VERI) with a Buy and raises the price target from $6 to $9.
10-20 18:35
Praxis Precision Medicines (NASDAQ:PRAX) said on Thursday it plans to offer shares of its common stock and prefunded warrants in a public offering, with all securities to be sold by the company. The s...
10-17 04:05
Shares of Veritone, Inc. (NASDAQ: VERI) are falling Thursday after the California-based company announced an equity offering.
10-17 00:03
Veritone ( ($VERI) ) has issued an announcement. On October 15, 2025, Veritone,...
10-16 20:58
Veritone, Inc. (NASDAQ:VERI) ("Veritone" or the "Company"), a leader in building human-centered enterprise AI solutions, today announced that it has entered into a definitive agreement providing for the purchase and sale
10-16 20:40